Luminescent MD is a life science R&D firm, developing medical instruments based on 1,1’-oxalyldiimidazole chemiluminescence (ODI CL) detection, and in-vitro diagnostic kits capable of sensing and quantifying biomarkers applied to early diagnosis and monitoring of various diseases (e.g., cancers, cardiac aliments, infectious diseases, diabetes). According to our preliminary data, using the medical instrument and in vitro diagnostic kits we are developing, it is now possible to quantify not only the biomarkers already being detected but also those yet to be detected by the existing automated diagnostic instruments.